Quest Diagnostics/DGX
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX
About Quest Diagnostics
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Ticker
DGX
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Providers and Services
Headquarters
Secaucus, United States
Employees
44,000
Website
www.questdiagnostics.com
DGX Metrics
BasicAdvanced
$15B
Market cap
18.39
P/E ratio
$7.43
EPS
0.89
Beta
$2.88
Dividend rate
2.11%
Dividend yield
Price and volume
Market cap
$15B
Beta
0.89
Dividend rate
$2.88
Financial strength
Current ratio
0.97
Quick ratio
0.782
Long term debt to equity
65.582
Total debt to equity
81.76
Dividend payout ratio (TTM)
37.71%
Interest coverage (TTM)
7.76%
Management effectiveness
Return on assets (TTM)
6.20%
Return on equity (TTM)
14.15%
Valuation
Price to earnings (TTM)
18.39
Price to revenue (TTM)
1.64
Price to book
2.36
Price to tangible book (TTM)
-5.86
Price to free cash flow (TTM)
16.12
Dividend yield (TTM)
2.11%
Growth
Revenue change (TTM)
-3.29%
Earnings per share change (TTM)
9.35%
3-year revenue growth
-3.50%
3-year earnings per share growth
-17.39%
3-year dividend per share growth
7.78%
What the Analysts think about DGX
Analyst Ratings
Majority rating from 18 analysts.
DGX Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2.4B
3.41%
Net income
$194M
1.04%
Profit margin
8.19%
-2.38%
DGX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.30
$2.22
$2.15
$2.04
-
Expected
$2.27
$2.19
$2.11
$1.86
$2.34
Surprise
1.48%
1.41%
1.70%
9.95%
-
DGX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
Jul
8
Quest Diagnostics
Dividend·Ex-dividend
Jul
22
Quest Diagnostics
Dividend·Payment
$0.75
Per share
FAQs
What’s the current market cap for Quest Diagnostics stock?
Quest Diagnostics (DGX) has a market cap of $15B as of July 03, 2024.
What is the P/E ratio for Quest Diagnostics stock?
The price to earnings (P/E) ratio for Quest Diagnostics (DGX) stock is 18.39 as of July 03, 2024.
Does Quest Diagnostics stock pay dividends?
Yes, the Quest Diagnostics (DGX) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $2.88 and the yield is 2.11%. Quest Diagnostics has a payout ratio of 37.71% on a trailing twelve-month basis.
When is the next Quest Diagnostics dividend payment date?
The next Quest Diagnostics (DGX) dividend payment is scheduled for July 22, 2024.
What is the beta indicator for Quest Diagnostics?
Quest Diagnostics (DGX) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Quest Diagnostics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.